Immunovant
In David Einhorn's portfolio · Greenlight Capital
Ticker IMVT
Still in the portfolio as of Q3 2026. Every quarter it shows up in a Greenlight Capital 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2026 | Reduce 25% | 70,140 | 0.1% |
| Q2 2026 | No change | 93,520 | 0.1% |
| Q1 2026 | Buy | 93,520 | 0.1% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.